Skip to main content

Peer Review reports

From: Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme

Original Submission
30 May 2023 Submitted Original manuscript
24 Jun 2023 Reviewed Reviewer Report - Madathan Kandi Sibin
2 Aug 2023 Reviewed Reviewer Report
24 Aug 2023 Author responded Author comments - Wen-Yu Cheng
Resubmission - Version 2
24 Aug 2023 Submitted Manuscript version 2
12 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Sep 2023 Editorially accepted
20 Sep 2023 Article published 10.1186/s12885-023-11400-5

You can find further information about peer review here.

Back to article page